Metabolic Acidosis Clinical Trial
Official title:
The Contribution of Intraoperative Mechanical Red Cell Salvage to Acidosis in the Immediate Postoperative Period After Cardiac Surgery
NCT number | NCT02800343 |
Other study ID # | AC16077 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 8, 2016 |
Est. completion date | July 31, 2016 |
Verified date | May 2024 |
Source | University of Edinburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Metabolic acidosis is a common complication that patients experience in the early postoperative period following cardiac surgery. Increasingly, the composition and volume of intravenous fluids administered during surgery have been implicated in the development of postoperative acidosis. Intraoperative Cell Salvage (ICS), an autologous blood transfusion technique employed by Cardiac/Perfusion Units to minimize blood loss during surgery, involves the infusion of of one such fluid, 0.9% sodium chloride. The rapid infusion of large volumes of 0.9% sodium chloride has previously been linked with the development of hyperchloraemic acidosis. It was therefore hypothesized that the volume of mechanically salvaged of red blood cells re-infused into patients undergoing heart surgery contributes to the acidosis that occurs in the early postoperative period. To test this, the investigators have designed an observational cohort study to check for correlation between the volume of cell salvaged blood infused during surgery and the severity of postoperative acidosis (which will be assessed using data from routine arterial blood gas samples).
Status | Completed |
Enrollment | 37 |
Est. completion date | July 31, 2016 |
Est. primary completion date | July 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years - Patients scheduled for cardiac surgery including both on- and off-pump coronary artery bypass grafting surgery, heart valve surgery, septal surgery, and aortic surgery) - Patients must have consented to participate Exclusion Criteria: - Patients under 18 years of age - Patients who are unable or unwilling to provide informed consent |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Royal Infirmary of Edinburgh | Edinburgh | Midlothian |
Lead Sponsor | Collaborator |
---|---|
University of Edinburgh | NHS Lothian |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | plasma hydrogen ion concentration | Plasma hydrogen ion concentration is measured by the arterial blood gas analyzer machine, and serves as a direct indicator of plasma acidity at a given time point.
Data from two routine blood gas samples are of interest: T1 - baseline measurement taken on insertion of an arterial line immediately after the induction of anaesthesia (i.e. before any fluid infusion has commenced); T2 - postoperative measurement made immediately after patient arrives in ICU (i.e. once all the cell salvaged blood has been transfused) |
at the start of surgery (before fluid infusion) and immediately after surgery (after fluid infusion) | |
Secondary | plasma chloride concentration | Plasma chloride concentration is measured by the arterial blood gas analyzer machine.
Data from two routine blood gas samples are of interest: T1 - baseline measurement taken on insertion of an arterial line immediately after the induction of anaesthesia (i.e. before any fluid infusion has commenced); T2 - postoperative measurement made immediately after patient arrives in ICU (i.e. once all the cell salvaged blood has been transfused) |
at the start of surgery (before fluid infusion) and immediately after surgery (after fluid infusion) | |
Secondary | plasma strong ion difference | Plasma strong ion difference can be computed from routine arterial blood gas electrolyte measurements (chloride, lactate, sodium, potassium) using a formula.
Strong ion difference serves as an indirect measure of plasma acidity. Data from two routine blood gas samples are of interest: T1 - baseline measurement taken on insertion of an arterial line immediately after the induction of anaesthesia (i.e. before any fluid infusion has commenced); T2 - postoperative measurement made immediately after patient arrives in ICU (i.e. once all the cell salvaged blood has been transfused) |
at the start of surgery (before fluid infusion) and immediately after surgery (after fluid infusion) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Completed |
NCT03317444 -
Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease
|
Phase 3 | |
Recruiting |
NCT05582824 -
Lactate Metabolism in the Hypoperfused Critically Ill
|
||
Active, not recruiting |
NCT04010630 -
Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU
|
N/A | |
Completed |
NCT02303548 -
Bicarbonate in Patients With Out-of-hospital Cardiac Arrest
|
Phase 2 | |
Recruiting |
NCT01860001 -
Incidence of Postoperative Ketosis and Metabolic Acidosis
|
N/A | |
Completed |
NCT01452412 -
Alkali Therapy in Chronic Kidney Disease
|
Phase 2/Phase 3 | |
Terminated |
NCT03710291 -
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
|
Phase 3 | |
Completed |
NCT02476253 -
Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill
|
Phase 3 | |
Completed |
NCT05940935 -
The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations
|
||
Withdrawn |
NCT03846258 -
High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
|
Phase 4 | |
Completed |
NCT05970094 -
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
|
N/A | |
Recruiting |
NCT05784389 -
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
|
N/A | |
Terminated |
NCT04727528 -
Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT02098356 -
Comparison of High Versus Low Bicarbonate Hemodialysis
|
N/A | |
Recruiting |
NCT03897101 -
Inflammation and Metabolic Acidosis at Birth (AGAIN: AutophaGy AcIdosis Newborn)
|
||
Terminated |
NCT01894594 -
Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
|
Phase 1 | |
Completed |
NCT01075750 -
Perioperative Fluid Management in Patients Receiving Cadaveric Renal Transplants
|
N/A | |
Completed |
NCT01293266 -
Effect of Propofol and Sevoflurane on Lactate During Anesthesia for Pediatric Heart Catheterisation
|
N/A | |
Completed |
NCT01295190 -
Substitution of Propofol by Sevoflurane During Pediatric Cardiopulmonary Bypass
|
N/A |